Healthcare -
Biotechnology - NASDAQ - US
$ 118.0
0.803 %
$ 11.3 B
Market Cap
76.62
P/E
SRPT - OPERATING INCOME
Operating Income SRPT - Sarepta Therapeutics, Inc.
-268 M
LAST VALUE
22.83%
2 YEAR CAGR
4.86%
5 YEAR CAGR
-11.49%
10 YEAR CAGR